Common Contracts
1 similar null contracts
Compassionate Use Treatment Support Agreement. Acuerdo de Apoyo al Tratamiento de Uso Compasivo.July 7th, 2022
This Agreement for Support of Compassionate Use Treatment (“Agreement”) is effective as of May[ 31 ], 2022, (hereinafter “Agreement Effective Date”) and is by and among ULTRAGENYX PHARMACEUTICAL INC., a Delaware corporation, having its principal place of business at 60 Leveroni Court, Novato, California 94949 (hereinafter “Ultragenyx”), the INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN, with offices located at Vasco de Quiroga 15, Tlalpan, México City, Not Applicable, 14000 Mexico (hereinafter the “Institution”), and Dr. ALFREDO ADOLFO REZA ALBARRÁN, M.D, attending physician at the Department of Endocrinology and Lipid Metabolism, (hereinafter the "Physician"), (each a “Party” and collectively the “Parties”). El presente Acuerdo de Apoyo al Tratamiento de Uso Compasivo ("Acuerdo") entra en vigor a partir del [ 31] de mayo del 2022, (en adelante "Fecha de entrada en Vigor del Acuerdo") y que firman por una primera parte ULTRAGENYX PHARMACEUTICAL INC., una corporaci
